169 related articles for article (PubMed ID: 28657744)
1. Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications.
Zhang G; Cheng J; McCorvy JD; Lorello PJ; Caldarone BJ; Roth BL; Kozikowski AP
J Med Chem; 2017 Jul; 60(14):6273-6288. PubMed ID: 28657744
[TBL] [Abstract][Full Text] [Related]
2. Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.
Cheng J; Giguère PM; Onajole OK; Lv W; Gaisin A; Gunosewoyo H; Schmerberg CM; Pogorelov VM; Rodriguiz RM; Vistoli G; Wetsel WC; Roth BL; Kozikowski AP
J Med Chem; 2015 Feb; 58(4):1992-2002. PubMed ID: 25633969
[TBL] [Abstract][Full Text] [Related]
3. Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT
Zhang G; McCorvy JD; Shen S; Cheng J; Roth BL; Kozikowski AP
Eur J Med Chem; 2019 Nov; 182():111626. PubMed ID: 31445232
[TBL] [Abstract][Full Text] [Related]
4. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
[TBL] [Abstract][Full Text] [Related]
5. Design and Discovery of Functionally Selective Serotonin 2C (5-HT
Cheng J; McCorvy JD; Giguere PM; Zhu H; Kenakin T; Roth BL; Kozikowski AP
J Med Chem; 2016 Nov; 59(21):9866-9880. PubMed ID: 27726356
[TBL] [Abstract][Full Text] [Related]
6. HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia.
Kozikowski AP; Cho SJ; Jensen NH; Allen JA; Svennebring AM; Roth BL
ChemMedChem; 2010 Aug; 5(8):1221-5. PubMed ID: 20533502
[No Abstract] [Full Text] [Related]
7. Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models.
Cheng J; Giguere PM; Schmerberg CM; Pogorelov VM; Rodriguiz RM; Huang XP; Zhu H; McCorvy JD; Wetsel WC; Roth BL; Kozikowski AP
J Med Chem; 2016 Jan; 59(2):578-91. PubMed ID: 26704965
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists.
Hansen M; Jacobsen SE; Plunkett S; Liebscher GE; McCorvy JD; Bräuner-Osborne H; Kristensen JL
Bioorg Med Chem; 2015 Jul; 23(14):3933-7. PubMed ID: 25583099
[TBL] [Abstract][Full Text] [Related]
9. Structural optimizations and bioevaluation of N-H aporphine analogues as G
Mao Q; Zhang B; Tian S; Qin W; Chen J; Huang XP; Xin Y; Yang H; Zhen XC; Shui W; Ye N
Bioorg Chem; 2022 Jun; 123():105795. PubMed ID: 35430417
[TBL] [Abstract][Full Text] [Related]
10. Selective 5-HT2C receptor agonists: Design and synthesis of pyridazine-fused azepines.
Green MP; McMurray G; Storer RI
Bioorg Med Chem Lett; 2016 Aug; 26(16):4117-21. PubMed ID: 27381086
[TBL] [Abstract][Full Text] [Related]
11. Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT
Carpenter J; Wang Y; Wu G; Feng J; Ye XY; Morales CL; Broekema M; Rossi KA; Miller KJ; Murphy BJ; Wu G; Malmstrom SE; Azzara AV; Sher PM; Fevig JM; Alt A; Bertekap RL; Cullen MJ; Harper TM; Foster K; Luk E; Xiang Q; Grubb MF; Robl JA; Wacker DA
J Med Chem; 2017 Jul; 60(14):6166-6190. PubMed ID: 28635286
[TBL] [Abstract][Full Text] [Related]
12. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
[TBL] [Abstract][Full Text] [Related]
13. Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptors.
Storer RI; Brennan PE; Brown AD; Bungay PJ; Conlon KM; Corbett MS; DePianta RP; Fish PV; Heifetz A; Ho DK; Jessiman AS; McMurray G; de Oliveira CA; Roberts LR; Root JA; Shanmugasundaram V; Shapiro MJ; Skerten M; Westbrook D; Wheeler S; Whitlock GA; Wright J
J Med Chem; 2014 Jun; 57(12):5258-69. PubMed ID: 24878222
[TBL] [Abstract][Full Text] [Related]
14. Amberlyst-15 catalysed synthesis of novel indole derivatives under ultrasound irradiation: Their evaluation as serotonin 5-HT
Reddy GS; Kamaraj R; Hossain KA; Kumar JS; Thirupataiah B; Medishetti R; Sushma Sri N; Misra P; Pal M
Bioorg Chem; 2021 Nov; 116():105380. PubMed ID: 34670330
[TBL] [Abstract][Full Text] [Related]
15. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
16. Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.
Cho SJ; Jensen NH; Kurome T; Kadari S; Manzano ML; Malberg JE; Caldarone B; Roth BL; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):1885-902. PubMed ID: 19284718
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT
Kim J; Kim YJ; Londhe AM; Pae AN; Choo H; Kim HJ; Min SJ
Molecules; 2019 Sep; 24(18):. PubMed ID: 31491978
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists.
Fevig JM; Feng J; Rossi KA; Miller KJ; Wu G; Hung CP; Ung T; Malmstrom SE; Zhang G; Keim WJ; Cullen MJ; Rohrbach KW; Qu Q; Gan J; Pelleymounter MA; Robl JA
Bioorg Med Chem Lett; 2013 Jan; 23(1):330-5. PubMed ID: 23177783
[TBL] [Abstract][Full Text] [Related]
19. Predicted structures and dynamics for agonists and antagonists bound to serotonin 5-HT2B and 5-HT2C receptors.
Kim SK; Li Y; Abrol R; Heo J; Goddard WA
J Chem Inf Model; 2011 Feb; 51(2):420-33. PubMed ID: 21299232
[TBL] [Abstract][Full Text] [Related]
20. Identification of Novel 1-
Mao Q; Zhang B; Li W; Tian S; Shui W; Ye N
ACS Chem Neurosci; 2020 Feb; 11(4):549-559. PubMed ID: 31968160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
